• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number VBJR052502A
Device Problems Device Damaged by Another Device (2915); Activation Failure (3270)
Patient Problem Perforation (2001)
Event Date 11/06/2018
Event Type  Injury  
Manufacturer Narrative
Review of device manufacturing record history confirmed device met pre-release specifications.Instructions for use (ifu) for gore® viabahn® endoprosthesis with heparin bioactive surface warnings section states, w.L.Gore & associates has insufficient clinical and experimental data regarding the use of the gore® viabahn® endoprosthesis within stents or stent grafts (other than the gore® viabahn® endoprosthesis with heparin bioactive surface or the gore® viabahn® endoprosthesis) that have been implanted for less than 30 days.Other devices implanted for less than 30 days may interfere with the deployment of the gore® viabahn® endoprosthesis resulting in deployment failure or other device malfunctions.
 
Event Description
The following was reported to gore: patient presented with thrombosis in superficial femoral artery (sfa).A zilver ptx stent was deployed first but blood flow was not re-established.Consequently, a gore® viabahn® endoprosthesis was advanced in order to cover the stenotic lesion.As reported, the zilver ptx stent and the viabahn device were at least 2 cm apart in the native vessel with no overlap.During deployment of the viabahn device, the device expanded about 2 cm when the deployment line became stuck.Further deployment was not possible.A longer sheath was inserted and attempts were made to capture the partially expanded viabahn device.In the process, the viabahn deployment line became entangled with the zilver ptx stent.As a result, a cut down was performed in the patient's right sfa.The viabahn device was cut into two sections and removed along with the zilver ptx stent.The artery was repaired and patient was sent to recovery.
 
Manufacturer Narrative
Device was released and returned from user facility.Field was populated.Code 213: engineering evaluation state the entire device was returned.The deployment knob was cut and separated from the deployment hub.About 2.5cm of deployment line was connected to the constrained end of the endoprosthesis at the transition.The distal shaft upon which the endoprosthesis is mounted, appeared to have been cut approximately 20.5cm from the transition.The endoprosthesis was cut along with the distal shaft, approximately 5cm from the tip.The endoprosthesis was partially expanded 1cm at the tip end.The inner braided constraining line was deployed approximately 1cm.Based on the device examination performed, no manufacturing anomalies were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8117731
MDR Text Key128856719
Report Number2017233-2018-00725
Device Sequence Number1
Product Code PFV
UDI-Device Identifier00733132623938
UDI-Public00733132623938
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 02/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/29/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/17/2021
Device Catalogue NumberVBJR052502A
Device Lot Number18390396
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/14/2019
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ZILVER PTX STENT, GUIDEWIRE, SHEATH
Patient Outcome(s) Required Intervention;
Patient Age73 YR
Patient Weight82
-
-